Syros Presents New Insights on Mechanism of Action of SY-1425, Its First-in-Class Selective RAR? Agonist, in Oral Plenary Session at AACR Hematologic Malignancies Conference
Stock Information for Syros Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.